When 'Younger' Skin Is Not a Blessing - New York Times


New York Times
When 'Younger' Skin Is Not a Blessing
New York Times
Laser and light therapy is an increasingly popular option in doctors' offices since studies in publications like the Journal of Cosmetic Laser Therapy and the Journal of Dermatological Treatment showed it to be effective on the reduction of ...

and more »

continue reading

Lumixyl® Topical Brightening System Demonstrates Effectiveness In Treating Melasma - MarketWatch (press release)

Lumixyl® Topical Brightening System Demonstrates Effectiveness In Treating Melasma
MarketWatch (press release)
... May 17, 2012 /PRNewswire via COMTEX/ -- Envy Medical announced that the May 2012 Journal of Drugs in Dermatology includes a report on case studies evaluating the effectiveness of the Lumixyl Topical Brightening System in the treatment of melasma.

and more »

continue reading

Esteemed Journal of the American Academy of Dermatology (JAAD) Publishes ... - MarketWatch (press release)

Esteemed Journal of the American Academy of Dermatology (JAAD) Publishes ...
MarketWatch (press release)
... FDA-cleared for the treatment of fine lines and wrinkles at-home. As a preeminent journal and resource for dermatologists, other physicians and the broader medical community, the JAAD is internationally known as the leading journal in its field.

and more »

continue reading

Do bald men face higher risk of prostate cancer? - wflx

Do bald men face higher risk of prostate cancer?
wflx
Find out more about your dermatological concerns and how to treat them.More >> Got hair? If you don't, you might have a higher risk of prostate cancer, a preliminary study suggests.More >> Got hair? If you don't, you might have a higher risk of ...

and more »

continue reading

New Study Determines that Radiation Therapy Offers Hope and Excellent ... - MarketWatch (press release)

New Study Determines that Radiation Therapy Offers Hope and Excellent ...
MarketWatch (press release)
... Marder Dermatology and Skin Cancer Center in Port Saint Lucie and Okeechobee, Florida ( www.marderdermatology.com ) has published a study in the May 2012 issue of the peer-reviewed journal, Cosmetic Dermatology. The study, titled "Radiation Therapy ...

and more »

continue reading

Sensus Healthcare and Texas Dermatology Associates at Baylor University ... - MarketWatch (press release)


PR Web (press release)
Sensus Healthcare and Texas Dermatology Associates at Baylor University ...
MarketWatch (press release)
Dr. Dan McCoy, who will lead the clinician content development team, said, "We are extremely excited to be involved in this project with Sensus Healthcare to bring this treatment modality back to the forefront of skin cancer therapy in dermatology and ...
Melanoma Patient Shares Cautionary Tale for Skin Cancer Awareness Month ... PR Web (press release)
Robert J. Loewinger: Recent cases bring to mind dangers of going in sun, using ... TCPalm

all 59 news articles »

continue reading

Two-Drug Combo May Be Safe for Melanoma Treatment - Health.com

Two-Drug Combo May Be Safe for Melanoma Treatment
Health.com
By Randy Dotinga WEDNESDAY, May 16 (HealthDay News) — A preliminary, first-stage study funded by a pharmaceutical company shows promising results for an experimental double-drug therapy for melanoma. The two drugs, known as dabrafenib and trametinib, ...

and more »

continue reading

Multilingual Science Content and New Rheumatology and Surgery Resources Published - Houston Chronicle

Multilingual Science Content and New Rheumatology and Surgery Resources Published
Houston Chronicle
Science Index's Health Section covers the effects of disease and medical treatment on the overall condition of organisms. Its eighteen subsections include Audiology, Dentistry, Dermatology, Endocrinology, Gastroenterology, Healthcare, Immunology, ...

and more »

continue reading

Two-Drug Combo May Be Safe for Melanoma Treatment - U.S. News & World Report

Two-Drug Combo May Be Safe for Melanoma Treatment
U.S. News & World Report
By Randy Dotinga WEDNESDAY, May 16 (HealthDay News) -- A preliminary, first-stage study funded by a pharmaceutical company shows promising results for an experimental double-drug therapy for melanoma. The two drugs, known as dabrafenib and trametinib, ...

and more »

continue reading

Melanoma Patient Shares Cautionary Tale for Skin Cancer Awareness Month ... - DigitalJournal.com (press release)

Melanoma Patient Shares Cautionary Tale for Skin Cancer Awareness Month ...
DigitalJournal.com (press release)
“Kelly was the perfect patient because she pursued treatment, and we caught her melanoma in the earliest phase possible,” Aasi said. If melanoma is diagnosed and treated early, it is almost always curable, but if it is not, the cancer can spread ...

and more »

continue reading